F 0605
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's
ability to function.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
clinical record review and staff interview, it was determined that the facility failed to ensure that residents
were free from potential chemical restraints for one of five sampled residents who were ordered
psychotropic medications. (Resident 26) Findings include:Clinical record review revealed that Resident 26
had diagnoses that included mood disorder and dementia. Review of the Minimum Data Set assessment
dated [DATE], revealed that the resident was cognitively impaired and had been administered an
anti-anxiety medication. On June 16, 2025, a physician ordered staff to administer an anti-anxiety
medication, (alprazolam), every eight hours as needed for anxiety and agitated behaviors. There was no
date in the order that indicated when staff was to stop administering the as needed medication. Review of
Resident 26's Medication Administration Record revealed that staff had administered the alprazolam 21
times in July 2025, 17 times in August 2025, and 17 times in September 2025. There was no documented
evidence that the physician had re-evaluated continued use beyond 14 days of the as needed anti-anxiety
medication. In an interview on September 23, 2025, at 8:50 a.m., the Administrator stated that there had
been no date added to the order that indicated when staff were to stop administering the anti-anxiety
medication. 28 Pa. Code 211.12(d)(1)(5) Nursing services.
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
395018
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395018
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/23/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Good Shepherd Home Raker Center
601 St John Street
Allentown, PA 18103
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0641
Ensure each resident receives an accurate assessment.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
clinical record review, observation, and staff interview, it was determined that the facility failed to ensure
that the Minimum Data Set (MDS) assessments were completed to accurately reflect the residents' current
status for three of 20 sampled residents. (Residents 1, 2, and 7)
Residents Affected - Few
Findings include:
Clinical record review revealed that Resident 1 had diagnoses that included cerebral atherosclerosis and
coronary artery disease. A physician's order dated July 1, 2025, directed staff to administer an anti-platelet
medication (clopidogrel bisulfate). Review of the MDS assessment dated [DATE], revealed that the resident
was administered an anti-coagulant medication during the review period, not an anti-platelet medication.
The MDS inaccurately reflected the use of an anti-coagulant medication.
Clinical record review revealed that Resident 2 had diagnoses that included peripheral artery disease and
depression. A physician's order dated October 9, 2023, directed staff to administer an anti-platelet
medication (clopidogrel bisulfate). Review of the MDS assessments dated June 12, 2025, and August 28,
2025, revealed that the resident was administered an anti-coagulant medication during the review period,
not an anti-platelet medication. The MDS assessments inaccurately reflected the use of an anti-coagulant
medication.
Clinical record review revealed that Resident 7 had diagnoses that included diabetes mellitus and
adjustment disorder. A physician's order dated November 23, 2021, directed staff to administer an
anti-depressant medication (sertraline). Review of the MDS assessment dated [DATE], revealed that the
resident was not administered an antidepressant medication and that the resident had received a dose of
insulin during the review period. Review of Resident 7's Medication Administration Record for August 2025
revealed that the resident did not receive any insulin and was administered an antidepressant medication in
the during the review period. The MDS inaccurately reflected administration of insulin and non-use of an
antidepressant medication.
In an interview on September 23, 2025, at 9:42 a.m., the Registered Nurse Assessment Coordinator
confirmed that Resident 1's, 2's, and 7's, MDS assessments were inaccurate and did not reflect the
residents' current status.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
395018
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395018
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/23/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Good Shepherd Home Raker Center
601 St John Street
Allentown, PA 18103
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0656
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Develop and implement a complete care plan that meets all the resident's needs, with timetables and
actions that can be measured.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
clinical record review and staff interview, it was determined that the facility failed to develop a
comprehensive care plan that addressed each resident's needs as identified in the comprehensive
assessment for two of 20 sampled residents. (Residents 16 and 36)Findings include: Clinical record review
revealed that Resident 16 was admitted to the facility on [DATE], and had diagnoses that included
adjustment disorder. The Minimum Data Set (MDS) Care Area Assessment (CAA) summary dated March
20, 2025, noted that the resident's psychotropic drug use was to be addressed in the care plan. Review of
the medication administration records for March through September 2025, revealed the resident received
an antidepressant (sertraline), which was classified as a psychotropic drug, during the review period. There
was no documented evidence that interventions to address Resident 16's psychotropic drug use were
included in the current care plan. In an interview on September 22, 2025, at 3:20 p.m., Registered Nurse 1
(RN1) confirmed there was no documented evidence that the psychotropic drug use was addressed in the
Resident's 16 current care plan. Clinical record review revealed that Resident 36 was admitted to the facility
on [DATE], and had diagnoses that included spastic quadriplegia cerebral palsy and seizure disorder.
Review of the MDS assessment dated [DATE], indicated that the resident received oxygen through her
nose while she was a resident. A physician's order dated September 9, 2021, instructed staff to apply
oxygen at two liters per minute through a nasal cannula every night. Review of the treatment administration
record for September 2025 revealed that the resident received oxygen every night. There was no
documented evidence that the use of oxygen was included in the resident's current care plan. In an
interview on September 23, 2025, at 9:45 a.m., RN2 confirmed that there was no documented evidence
that oxygen was addressed on Resident 36's current care plan. 28 Pa. Code 211.12(d)(1)(5) Nursing
services.
Event ID:
Facility ID:
395018
If continuation sheet
Page 3 of 3